Home | Symbol Index | About |

Actividentity Corporation (ACTI) > Trackbacks

Active Biotech: Laquinimod Phase IIb Trial confirms efficacy and favorable safety profile and shows significant reduction in the rate of inflammatory disease activity

Tue, 5 Sep 2006 8:02:00 PDT

LUND, SWEDEN (MARKET WIRE) The once-daily novel oral agent for relapsing remitting multiple sclerosis (MS) patients met its primary endpoint

Trackbacks

A trackback is a mechanism for communication between blogs. The following blog entries have been detected that are in reference to Active Biotech: Laquinimod Phase IIb Trial confirms efficacy and favorable safety profile and shows significant reduction in the rate of inflammatory disease activity.


What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.




Powered by Odin Assemble 2.5a